
Novel pan-caspase ингибитор, potently reducing not only inflammasome-mediated interleukin-1β (IL-1β) secretion but also osteoclast differentiation in BMMs
Novel pan-caspase inhibitor, potently reducing not only inflammasome-mediated interleukin-1β (IL-1β) secretion but also osteoclast differentiation in BMMs
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.